Gerard Christopher's Form 4 filing
Amedisys Inc (AMED) · filed Aug 4, 2021
- Accession no.
- 0000896262-21-000102
- Filed
- Aug 4, 2021
- Trade date
- Aug 2, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $326.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gerard ChristopherCIK 0001694097 | Officer (President & COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2021 | Common Stock | SSaleDisposed | −100 | $257.44 | −$25,744 | 39,006 | Direct | |
| Aug 2, 2021 | Common Stock | SSaleDisposed | −450 | $260.66 | −$117,297 | 38,556 | Direct | |
| Aug 2, 2021 | Common Stock | SSaleDisposed | −500 | $261.73 | −$130,865 | 38,056 | Direct | |
| Aug 2, 2021 | Common Stock | SSaleDisposed | −200 | $263.19 | −$52,638 | 37,856 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.